Progesterone Action in Endometrial Cancer, Endometriosis, Uterine Fibroids, and Breast Cancer

Abstract

Progesterone receptor (PR) mediates the actions of the ovarian steroid progesterone, which together with estradiol regulates gonadotropin secretion, prepares the endometrium for implantation, maintains pregnancy, and differentiates breast tissue. Separation of estrogen and progesterone actions in hormone-responsive tissues remains a challenge. Pathologies of the uterus and breast, including endometrial cancer, endometriosis, uterine fibroids, and breast cancer, are highly associated with estrogen, considered to be the mitogenic factor. Emerging evidence supports distinct roles of progesterone and its influence on the pathogenesis of these diseases. Progesterone antagonizes estrogen-driven growth in the endometrium, and insufficient progesterone action strikingly increases the risk of endometrial cancer. In endometriosis, eutopic and ectopic tissues do not respond sufficiently to progesterone and are considered to be progesterone-resistant, which contributes to proliferation and survival. In uterine fibroids, progesterone promotes growth by increasing proliferation, cellular hypertrophy, and deposition of extracellular matrix. In normal mammary tissue and breast cancer, progesterone is pro-proliferative and carcinogenic. A key difference between these tissues that could explain the diverse effects of progesterone is the paracrine interactions of PR-expressing stroma and epithelium. Normal endometrium is a mucosa containing large quantities of distinct stromal cells with abundant PR, which influences epithelial cell proliferation and differentiation and protects against carcinogenic transformation. In contrast, the primary target cells of progesterone in the breast and fibroids are the mammary epithelial cells and the leiomyoma cells, which lack specifically organized stromal components with significant PR expression. This review provides a unifying perspective for the diverse effects of progesterone across human tissues and diseases.

Lipid profile, cardiorespiratory function and quality of life of postmenopausal women improves with aerobic exercise

“…It was affirmed that menopause as a life event has no effect on quality of life but the presence and intensity of climacteric symptoms may have a negative impact on all the aspects of quality of life (Kim et al, 2013). Despite a submission that physical, social and psychological changes that occur during the menopausal stage of women have negative effects on their QoL (Teoman, Özcan, & Acar, 2004), there has been presumption that ethnic diversity may be responsible for differences in quality of life of individuals in different geographical locations (Heringa et al, 2015).…”

Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors

“…5,6 In contrast, an understanding of the actions of progestins in the development and progression of breast cancer is controversial. 7,8 In general, it is thought that progestins can both inhibit and stimulate proliferation of breast cancer cells. 9 The Women's Health Initiative Study firmly established that treatment with progestin in combination with estrogen (E2) for attenuating postmenopausal symptoms increases the risk of breast cancer, particularly TNBC.…”

A Role for Phaleria Macrocarpa (Scheff) Boerl. Extracts in the Management of Women’s Pathological Conditions: A Research Review

“…Endometriotic tissue produces large quantities of progesterone and contains much lower levels of progesterone receptors than endometrium [34]. Progesterone, induces much lower levels of prolactin expression in endometriotic cells compared to endometrial stromal cells, suggesting that progesterone resistance may lead to endometriosis.…”

“…Progesterone resistance is increased by the low progesteronereceptor levels in endometriotic tissue. In endometriotic tissue, levels of progesterone receptor isoform B (PR-B) is undetectable, while that of the progesterone receptor isoform A (PR-A) isoform is markedly reduced, in endometriotic tissues [29,34].…”